NSE: CONCORDBIO
CONCORD BIOTECH LIMITED
Latest available quote
CONCORD BIOTECH LIMITED
NSE: CONCORDBIO
₹632.60
-40.10 (-5.96%)
Open
656.00
High
663.00
Low
622.30
Prev close
672.70
Last trade 6/11/2026, 3:57:46 pm IST. Last successful check 8/11/2026, 11:38:30 am IST. Prices from NSE via Upstox, checked every 30 seconds; provider delays may apply. For information only.
Price history
-10.90% over 3M
Performance
52-week range
Position in day range
CONCORDBIO stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Sideways
50-DMA ₹694.95
RSI (14)
45
Neutral momentum
Volatility (ATR)
6.33%
High
Close streak
1d down
Volume vs 20d avg
0.87x
From 52W high
-21.66%
Up from 52W low
+28.19%
Green days (20)
11/20
Monthly seasonality
Average monthly move for CONCORDBIO across the available price history.
Key statistics
Open
656
Day high
663
Day low
622.3
Prev close
672.7
Volume
2.59 L
Avg vol (20d)
2.99 L
52W high
807.5
52W low
493.5
CONCORDBIO quarterly results
All CONCORDBIO results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹309 cr
+25.1% YoY
Net profit
₹70.65 cr
+11.1% YoY
Operating profit
₹86 cr
+22.7% YoY
EPS
₹6.65
+10.3% YoY
Swipe sideways to see all columns →
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q2 FY272026-09-30 | ₹309 cr | ₹86 cr | ₹70.65 cr | 27.8% | 22.9% | ₹6.65 | +11.1% | +22.5% |
| Q1 FY272026-06-30 | ₹257 cr | ₹64.28 cr | ₹57.7 cr | 25.0% | 22.4% | ₹8.46 | — | -35.0% |
| Q4 FY262026-03-31 | ₹326 cr | ₹98.99 cr | ₹88.79 cr | 30.4% | 27.2% | ₹8.46 | — | +39.5% |
| Q3 FY262025-12-31 | ₹278 cr | ₹80.23 cr | ₹63.64 cr | 28.9% | 22.9% | ₹6.08 | — | +0.1% |
| Q2 FY262025-09-30 | ₹247 cr | ₹70.1 cr | ₹63.58 cr | 28.4% | 25.7% | ₹6.03 | — | — |
| TTM (last 4 quarters) | ₹1,170 cr | ₹330 cr | ₹281 cr | 28.2% | 24.0% | ₹29.65 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
Corporate Action Story Puts Concord Biotech in Play: Share Price Opened Gap-Down at ₹1,540.20, and Here Is the Arithmetic
Concord Biotech (CONCORDBIO) last traded at ₹1,560.30, +27.90 (+1.79%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
CONCORDBIO Jumped 5.38% to ₹1,579.40: Inside the Corporate Action Story Moving Concord Biotech Shares
Concord Biotech (CONCORDBIO) last traded at ₹1,579.40, +85.00 (+5.38%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Latest market news
Industry and Sectors Tops Midday Market Talk on 8 November 2026
Financial news desks prioritize industry and sectors alongside manufacturing, technology, and energy as of 11:05 am IST on 8 November 2026 across major newswires.
Ethereum Price Drops 7.67% to $2,236.48 as Crypto Market Slides
Ethereum falls 7.67% to $2,236.48 as of 05:30 am IST on 8 November 2026, leading a broader sell-off across major digital assets including Bitcoin and XRP.
Morning Market Buzz, 8 November 2026: Quarterly Results Tops the Coverage Ahead of IPOs and Industry And Sectors
The most-covered market themes in the morning session on 8 November 2026 — quarterly results, IPOs, industry and sectors — with our live numbers for each and links to the publishers running the story.
Evening Market Focus on 7 November 2026: Industry and Sectors Leads
Industry and sectors tops desk coverage with 7 headlines across 4 publishers as of 07:05 pm IST on 7 November 2026, followed closely by IT and mutual funds.
Tata Steel Limited Q2 FY27 Results: Net Profit ₹3,700 cr
Tata Steel Limited Q2 FY27 consolidated results: revenue from operations of ₹65,436 cr and net profit of ₹3,700 cr.
Divi's Laboratories Limited Q2 FY27 Results: Net Profit ₹1,127 cr
Divi's Laboratories Limited Q2 FY27 consolidated results: revenue from operations of ₹3,676 cr and net profit of ₹1,127 cr.
Price and history data from NSE via Upstox. For information only, not investment advice.